Konrad Hochedlinger, PhD

Associate Professor of Medicine,

Harvard University Department of Stem Cell and Regenerative Biology

Massachusetts General Hospital

“Reprogramming Cell Fate With Transcription Factors”

Share with friends

Added: April 12, 2022

Related News

Latest publication from the Murphy Lab featured on the cover of Blood Advances: De Novo Hematopoiesis from the Fetal Lung!

Hemogenic endothelial cells (HECs) are specialized cells that undergo endothelial-to-hematopoietic transition (EHT) to give rise

New publication from the Murphy Lab in Science Advances! They led a Team demonstrating that immune cells drive NET tumor progression and susceptibility to therapies

Neuroendocrine tumors (NETs) are rare cancers that most often arise in the gastrointestinal tract and

Kotton Lab featured in Boston University Article on Lung Disease Research

For more than 20 years, a team of Boston University scientists have been on a

The Mostoslavsky Lab Publishes New Platform to Make T Cells from iPSCs

A robust method of producing mature T cells from iPSCs is needed to realize their


Location The Center for Regenerative Medicine 670 Albany St 2nd Floor Boston MA 02118 Boston University & Boston Medical Center

Quick links

Research at the CReM

Cores & Protocols

CReM Labs

Connect

© 2021 CReM. All Rights Reserved.

Positions available Financial Support CReM response to COVID-19

Privacy policy Terms of use